Literature DB >> 8396230

Ulex europaeus agglutinin-1 binding in hereditary bowel cancer.

J R Jass1, L J Allison, S M Stewart, M R Lane.   

Abstract

Ulex europaeus agglutinin-1 (UEA-1) binds specifically to alpha-L-fucose, the terminal sugar of blood group substances H2 and Ley the expression of which is confined mainly to the proximal colon. The aim of the study was to determine whether there is neo-expression of alpha-L-fucose in the normal appearing mucosa of the distal bowel in subjects with or at risk of hereditary bowel cancer. UEA-1 binding was investigated by means of a direct lectin-peroxidase technique in tissues derived from patients with familial adenomatous polyposis (9) and affected (16) or at risk of (14) hereditary non-polyposis colorectal cancer. Control tissues were obtained from normal subjects and patients with sporadic bowel cancer and no family history of the condition. There was increased expression of alpha-L-fucose in some adenomas (mosaic pattern), in most carcinomas (diffuse), in hyperplastic polyps (crypt base), but not in normal appearing mucosa or transitional mucosa (adjacent to carcinoma) in any of the groups of patients examined. In view of the negative findings for normal-appearing mucosa, the suggestion that there is a pre-neoplastic field change in subjects at risk of hereditary bowel cancer may be unfounded.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396230     DOI: 10.3109/00313029309084782

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  2 in total

1.  Lack of mucin MUC5AC field change expression associated with tubulovillous and villous colorectal adenomas.

Authors:  R J Longman; J Douthwaite; P A Sylvester; D O'Leary; B F Warren; A P Corfield; M G Thomas
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  Relationship between the nature of mucus and crypt multiplicity in aberrant crypt foci in the rat colon.

Authors:  K Uchida; S Kado; M Onoue; K Tohyama
Journal:  Jpn J Cancer Res       Date:  1997-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.